Selank
A synthetic peptide approved as a medicine in Russia; not FDA-approved in the United States.
What it is
Selank is a synthetic peptide developed in Russia, derived from an immune-related fragment called tuftsin, and studied there for anxiety-related indications. It holds regulatory status as a medicine in Russia but not in the United States or Europe.
The published human research comes largely from the originating Russian institutions — small studies without the independent replication Western approval would require. In the US it circulates as a nasal-spray gray-market product.
What researchers have actually studied it for
Anxiety-related indications in Russian clinical studies; approved as a medicine in Russia, unapproved and unreviewed by FDA.
How it works
A tuftsin analog with a stabilizing tail, proposed to modulate GABA signaling, influence brain-derived neurotrophic factor (BDNF), and adjust monoamine turnover — an anxiolytic profile without sedation, per the originating literature. Mechanistic work is largely from Russian institutes and animal models.
The molecule itself
A heptapeptide: tuftsin's four amino acids (TKPR) plus a PGP stabilizing tail. Tuftsin itself is an immunoglobulin fragment — making Selank an immune-signaling excerpt repurposed for the brain, administered intranasally because peptide oral bioavailability is negligible.
Where it came from
Developed at Moscow's Institute of Molecular Genetics from tuftsin — an immune peptide discovered in the 1970s — Selank won Russian registration as an anxiolytic in 2009. It is a flagship of Russia's distinct regulatory peptide tradition, which the Western nootropics community mail-orders around.
The timeline
1970s
Tuftsin discovered as an immune-stimulating antibody fragment.
1990s
Moscow's Institute of Molecular Genetics engineers the stabilized analog.
2009
Registered in Russia as an anxiolytic.
2010s+
Western nootropics adoption via gray-market import.
What the research record actually contains
- Russian clinical studies in anxiety disorders reporting benefit without sedation or dependence.
- Animal mechanistic literature on GABA and BDNF pathways.
- No independent Western randomized trials; no FDA review of any kind.
What could change this assessment
No Western development exists; its file will stay regional unless psychoneuroimmunology's growing interest in immune-anxiety signaling happens to revisit tuftsin biology. Import-channel product quality remains the practical variable.
What's known about risks
Russian literature reports good tolerability in small studies. No independent large-scale safety characterization exists, and imported spray products carry the usual unregulated-sourcing unknowns.
Where it stands legally
A registered medicine in Russia; in the US neither approved nor lawfully sold as a supplement — a personal-import gray zone.
Worth asking a licensed provider
- 1.For my anxiety picture, what evidence-based options — therapy and approved medications — haven't we tried?
- 2.How would we evaluate a compound whose entire evidence base can't be independently verified?
- 3.What are the risks of self-treating anxiety outside any monitoring?
Common claims, corrected
“It's a proven benzo alternative.”
Reality: Its no-sedation, no-dependence profile comes from small regional studies not designed to detect dependence — promising if replicated, and unreplicated.
“Approved in Russia means vetted.”
Reality: It means vetted by a different system with different standards — evidence in another regulatory language that Western review never translated.
Selank FAQ
Is Selank approved anywhere?
In Russia, yes. It has no FDA approval and no published FDA review — 'approved abroad' and 'approved' are different claims for a US reader.
What does Selank do?
Russian studies report anti-anxiety effects without sedation. Those studies are small and haven't been independently replicated — an interesting signal, not established medicine.
Is Selank safe?
Its safety profile hasn't been characterized in the large controlled trials US approval requires. Russian literature reports good tolerability in small studies; unregulated sourcing adds the usual unknowns.
Why is Selank taken as a nasal spray?
Peptides don't survive digestion, and the nasal route offers modest absorption plus the (research-stage) olfactory pathway argument — practical necessity marketed as targeting.
What is tuftsin, its parent?
A four-amino-acid antibody fragment that stimulates immune cells — one of immunology's early peptide discoveries, making Selank's anxiolytic career a genuinely odd repurposing story.